Literature DB >> 26227741

Endothelial Function Predicts New Hospitalization due to Heart Failure Following Cardiac Resynchronization Therapy.

Kunio Yufu1, Tetsuji Shinohara1, Yuki Ebata1, Reika Ayabe1, Akira Fukui1, Norihiro Okada1, Mikiko Nakagawa1, Naohiko Takahashi1.   

Abstract

BACKGROUND: Cardiac resynchronization therapy (CRT) has been established as a treatment for patients with chronic heart failure (HF). We tested the hypothesis that assessment of peripheral endothelial function is associated with the long-term outcome of CRT and its linkage to coronary flow reserve (CFR) was also investigated.
METHODS: From 2010, a total of 34 consecutive patients implanted with CRT for the treatment of advanced HF were evaluated at baseline (immediately before CRT) and 6-8 months after CRT. Endothelial function was evaluated by measurement of reactive hyperemia peripheral arterial tonometry (RH-PAT). In 24 of 34 patients, CFR was determined by transthoracic echocardiography.
RESULTS: Based on the receiver-operating characteristic curves, depressed RH-PAT index (RHI) was defined as ≤1.5. Accurate follow-up information during the mean of 343 ± 120 days was obtained in 20 preserved RHI group (mean age 66 ± 1.8 years) and 14 depressed RHI group (71 ± 2.2 years). Kaplan-Meier survival analysis demonstrated that depressed RHI group had higher prevalence of new hospitalization due to HF progression (log-rank 5.40). Cox proportional hazards regression analysis revealed that the baseline log brain natriuretic peptide (hazard ratio 5.95) and the baseline RHI value (hazard ratio 0.066) were independently associated with the incidence of new hospitalization due to HF progression. The baseline RHI values were positively correlated with the 6-8 months change of CFR (R = 0.434, P = 0.0343).
CONCLUSIONS: Our results suggest that the baseline peripheral endothelial function could predict the long-term outcome of CRT. The results also suggest that improvement of coronary microcirculation might be associated with the better baseline endothelial function.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  cardiac resynchronization therapy; coronary flow reserve; endothelial function; long-term outcome

Mesh:

Year:  2015        PMID: 26227741     DOI: 10.1111/pace.12698

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Assessment of coronary flow reserve predicts long-term outcome of responders to cardiac resynchronization therapy.

Authors:  Kunio Yufu; Hidekazu Kondo; Tetsuji Shinohara; Yumi Ishii; Seiichiro Yoshimura; Ichitaro Abe; Shotaro Saito; Akira Fukui; Norihiro Okada; Hidefumi Akioka; Yasushi Teshima; Mikiko Nakagawa; Naohiko Takahashi
Journal:  Heart Vessels       Date:  2018-11-27       Impact factor: 2.037

2.  Endothelial dysfunction and glycocalyx shedding in heart failure: insights from patients receiving cardiac resynchronisation therapy.

Authors:  Chukwudiebube N Ajaero; Nathan E K Procter; Yuliy Y Chirkov; Tamila Heresztyn; Margaret A Arstall; Andrew D McGavigan; Michael P Frenneaux; John D Horowitz
Journal:  Heart Vessels       Date:  2019-08-27       Impact factor: 2.037

3.  Peripheral endothelial dysfunction is a novel risk factor for systolic dysfunction and heart failure progression.

Authors:  Riad Taher; Jaskanwal D Sara; Takumi Toya; Barry A Borlaug; Lilach O Lerman; Amir Lerman
Journal:  Int J Cardiol Heart Vasc       Date:  2020-07-23

Review 4.  Flow-mediated dilation and heart failure: a review with implications to physical rehabilitation.

Authors:  G P T Areas; A Mazzuco; F R Caruso; R B Jaenisch; R Cabiddu; S A Phillips; R Arena; A Borghi-Silva
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

5.  Association between reactive hyperemia peripheral arterial tonometry index and atrial fibrillation recurrence after catheter ablation.

Authors:  Hideki Kobayashi; Ayako Okada; Hiroaki Tabata; Wataru Shoin; Takahiro Okano; Koji Yoshie; Yasutaka Oguchi; Ken Kato; Morio Shoda; Koichiro Kuwahara
Journal:  Int J Cardiol Heart Vasc       Date:  2019-06-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.